Patent details

EP3660512 Title: NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF

Basic Information

Publication number:
EP3660512
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP192061232
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF
French Title of Invention:
BIOMARQUEURS DE LA MALADIE DU FOIE GRAS NON ALCOOLIQUE (NAFLD) ET DE LA STÉATOHÉPATITE NON ALCOOLIQUE (NASH) ET LEURS UTILISATIONS
German Title of Invention:
BIOMARKER FÜR NICHTALKOHOLISCHE FETTLEBERERKRANKUNG UND NICHTALKOHOLISCHE STEATOHEPATITIS UND VERWENDUNGEN DAVON
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
23/08/2024
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
02/09/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
24/07/2024
Unitary Effect Registration Date:
02/09/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
10/03/2014
Grant date:
24/07/2024
EP Publication Date:
03/06/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/07/2024
EP B1 Publication Date:
24/07/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
10/03/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/07/2024
 
 

Name:
SomaLogic Operating Co., Inc.
Address:
2945 Wilderness Place, Boulder, CO 80301, United States (US)

Inventor

1

Name:
WILLIAMS, Stephen Alaric
Address:
United States (US)

2

Name:
FIELD, Stuart G.
Address:
United States (US)

3

Name:
NIKRAD, Malti
Address:
United States (US)

Priority

Priority Number:
201361787967 P
Priority Date:
15/03/2013
Priority Country:
United States (US)

Classification

IPC classification:
G01N 33/68;

Publication

European Patent Bulletin

1

Issue number:
202430
Publication date:
24/07/2024
Description:
Grant (B1)

2

Issue number:
202440
Publication date:
02/10/2024
Description:
Unitary Effect Request Receipt

3

Issue number:
202440
Publication date:
02/10/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages